Yong-Qiang Deng (Yongqiang Deng)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 21

Top Venues

Signal transduction and targeted therapy

Cell discovery

Science (New York, N.Y.)

Nature

This page only lists publications with an associated author ORCID identifier.

Publications

Hang Chi, Suo-Qun Zhao, Ru-Yi Chen, Xing-Xing Suo, Rong-Rong Zhang, Wen-Hui Yang, Dong-Sheng Zhou, Min Fang, Bo Ying, Yong-Qiang Deng, Cheng-Feng Qin
Rapid development of double-hit mRNA antibody cocktail against orthopoxviruses. Signal transduction and targeted therapy 9 (1) (2024)
Hang Chi, Suo-Qun Zhao, Ru-Yi Chen, Xing-Xing Suo, Rong-Rong Zhang, Wen-Hui Yang, Dong-Sheng Zhou, Min Fang, Bo Ying, Yong-Qiang Deng, Cheng-Feng Qin
Rapid development of double-hit mRNA antibody cocktail against orthopoxviruses. Signal transduction and targeted therapy 9 (1) (2024)
Hang Chi, Suo-Qun Zhao, Ru-Yi Chen, Xing-Xing Suo, Rong-Rong Zhang, Wen-Hui Yang, Dong-Sheng Zhou, Min Fang, Bo Ying, Yong-Qiang Deng, Cheng-Feng Qin
Rapid development of double-hit mRNA antibody cocktail against orthopoxviruses. Signal transduction and targeted therapy 9 (1) (2024)
Qi Qi, Qi Chen, Yumei Dong, Kun Wang, Jialu Wang, Guiming Jin, Aiping Zheng, Rong Zhang, Yong-Qiang Deng, Yuhuan Li, Chengfeng Qin, Xiaotao Duan
Oral administration of D-glucosamine confers broad-spectrum protection against human coronaviruses including SARS-CoV-2. Signal transduction and targeted therapy 8 (1) (2023)
Xing-Yao Huang, Qi Chen, Meng-Xu Sun, Hang-Yu Zhou, Qing Ye, Wu Chen, Jin-Yu Peng, Yi-Ni Qi, Jun-Qiong Zhai, Ying Tian, Zi-Xin Liu, Yi-Jiao Huang, Yong-Qiang Deng, Xiao-Feng Li, Aiping Wu, Xiao Yang, Guan Yang, Yongyi Shen, Cheng-Feng Qin
A pangolin-origin SARS-CoV-2-related coronavirus: infectivity, pathogenicity, and cross-protection by preexisting immunity. Cell discovery 9 (1) (2023)
Yisheng Jiang, Yong-Qiang Deng, Huanhuan Pang, Tiantian Ma, Qing Ye, Qi Chen, Haiyang Chen, Ze-Ping Hu, Cheng-Feng Qin, Zhiheng Xu
Treatment of SARS-CoV-2-induced pneumonia with NAD + and NMN in two mouse models. Cell discovery 8 (1) (2022)
Luming Wan, Qi Gao, Yong-Qiang Deng, Yuehua Ke, Enhao Ma, Huan Yang, Haotian Lin, Huilong Li, Yilong Yang, Jing Gong, Jingfei Li, Yixin Xu, Jing Liu, Jianmin Li, Jialong Liu, Xuemiao Zhang, Linfei Huang, Jiangyue Feng, Yanhong Zhang, Hanqing Huang, Huapeng Wang, Changjun Wang, Qi Chen, Xingyao Huang, Qing Ye, Dongyu Li, Qiulin Yan, Muyi Liu, Meng Wei, Yunhai Mo, Dongrui Li, Ke Tang, Changqing Lin, Fei Zheng, Lei Xu, Gong Cheng, Pei-Hui Wang, Xiaopan Yang, Feixiang Wu, Zhiwei Sun, Cheng-Feng Qin, Congwen Wei, Hui Zhong
GP73 is a glucogenic hormone contributing to SARS-CoV-2-induced hyperglycemia. Nature metabolism 4 (1) (2022)
Yong-Qiang Deng, Na-Na Zhang, Yi-Fei Zhang, Xia Zhong, Sue Xu, Hong-Ying Qiu, Tie-Cheng Wang, Hui Zhao, Chao Zhou, Shu-Long Zu, Qi Chen, Tian-Shu Cao, Qing Ye, Hang Chi, Xiang-Hui Duan, Dan-Dan Lin, Xiao-Jing Zhang, Liang-Zhi Xie, Yu-Wei Gao, Bo Ying, Cheng-Feng Qin
Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters. Cell research 32 (4) (2022)
Kang Wang, Zijing Jia, Linilin Bao, Lei Wang, Lei Cao, Hang Chi, Yaling Hu, Qianqian Li, Yunjiao Zhou, Yinan Jiang, Qianhui Zhu, Yong-Qiang Deng, Pan Liu, Nan Wang, Lin Wang, Min Liu, Yurong Li, Boling Zhu, Kaiyue Fan, Wangjun Fu, Peng Yang, Xinran Pei, Zhen Cui, Lili Qin, Pingju Ge, Jiajing Wu, Shuo Liu, Yiding Chen, Wei Jin Huang, Qiao Wang, Cheng-Feng Qin, You-Chun Wang, Chuan Qin, Xiangxi Wang
Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants. Nature 603 (7903) (2022)
Shihui Sun, Hongjing Gu, Lei Cao, Qi Chen, Qing Ye, Guan Yang, Rui-Ting Li, Hang Fan, Yong-Qiang Deng, Xiaopeng Song, Yini Qi, Min Li, Jun Lan, Rui Feng, Yan Guo, Na Zhu, Si Qin, Lei Wang, Yi-Fei Zhang, Chao Zhou, Lingna Zhao, Yuehong Chen, Meng Shen, Yujun Cui, Guan Yang, Xinquan Wang, Wenjie Tan, Hui Wang, Xiangxi Wang, Cheng-Feng Qin
Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2. Nature communications 12 (1) (2021)
Te Liang, Mengli Cheng, Fei Teng, Hongye Wang, Yong-Qiang Deng, Jiahui Zhang, Cheng-Feng Qin, Shubin Guo, Hui Zhao, Xiaobo Yu
Proteome-wide epitope mapping identifies a resource of antibodies for SARS-CoV-2 detection and neutralization. Signal transduction and targeted therapy 6 (1) (2021)
Yi-Jiao Huang, Hui Zhao, Xun Huang, Yong-Qiang Deng, Xiao-Feng Li, Qing Ye, Rui-Ting Li, Yan-Peng Xu, Tian-Shu Cao, Cheng-Feng Qin
Identification of oligosaccharyltransferase as a host target for inhibition of SARS-CoV-2 and its variants. Cell discovery 7 (1) (2021)
Jiejie Geng, Liang Chen, Yufeng Yuan, Ke Wang, You-Chun Wang, Chuan Qin, Guizhen Wu, Ruo Chen, Zheng Zhang, Ding Wei, Peng Du, Jun Zhang, Peng Lin, Kui Zhang, Yong-Qiang Deng, Ke Xu, Jiangning Liu, Xiuxuan Sun, Ting Guo, Xu Yang, Jiao Wu, Jianli Jiang, Ling Li, Kun Zhang, Zhe Wang, Jing Zhang, Qingguo Yan, Hua Zhu, Zhaohui Zheng, Jinlin Miao, Xianghui Fu, Fengfan Yang, Xiaochun Chen, Hao Tang, Yang Zhang, Ying Shi, Yumeng Zhu, Zhuo Pei, Fei Huo, Xue Liang, Yatao Wang, Qingyi Wang, Wen Xie, Yirong Li, Mingyan Shi, Hui-Jie Bian, Ping Zhu, Zhi-Nan Chen
CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma. Signal transduction and targeted therapy 6 (1) (2021)
Hui Zhao, Tie-Cheng Wang, Xiao-Feng Li, Na-Na Zhang, Liang Li, Chao Zhou, Yong-Qiang Deng, Tian-Shu Cao, Guan Yang, Rui-Ting Li, Yi-Jiao Huang, Yuan-Guo Li, Yi-Ming Zhang, Fang-Xu Li, Yu-Ren Zhou, Yu-Hang Jiang, Xi-Shan Lu, Shi-Hui Sun, Meng-Li Cheng, Kai-Ping Gu, Mei Zhang, Qing-Qing Ma, Xiao Yang, Bo Ying, Yu-Wei Gao, Cheng-Feng Qin
Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates. Signal transduction and targeted therapy 6 (1) (2021)
Shulong Zu, Dan Luo, Lili Li, Qing Ye, Rui-Ting Li, Yanan Wang, Meiling Gao, Heng Yang, Yong-Qiang Deng, Genhong Cheng
Tamoxifen and clomiphene inhibit SARS-CoV-2 infection by suppressing viral entry. Signal transduction and targeted therapy 6 (1) (2021)
Junli Liu, Qi Chen, Shumin Yang, Ying Li, Yang Dou, Yong-Qiang Deng, Jinpeng Bi, Yongcong Tan, Hongfan Wang, Wei Gong, Xiaoyu Xu, Zhenhu Li, Guojun Lang, Cheng-Feng Qin, Bai Lu, Weidong Jiang
hACE2 Fc-neutralization antibody cocktail provides synergistic protection against SARS-CoV-2 and its spike RBD variants. Cell discovery 7 (1) (2021)
Hongyue Li, Yuhang Zhang, Dong Li, Yong-Qiang Deng, Hongde Xu, Chaoyue Zhao, Jiandong Liu, Dan Wen, Jianguo Zhao, Yongchun Li, Yong Wu, Shujun Liu, Jiankai Liu, Junfeng Hao, Fei Yuan, Shuguang Duo, Cheng-Feng Qin, Ai-Hua Zheng
Enhanced protective immunity against SARS-CoV-2 elicited by a VSV vector expressing a chimeric spike protein. Signal transduction and targeted therapy 6 (1) (2021)
Deyong Song, Wenbo Wang, Chuangchuang Dong, Zhenfei Ning, Xiu Liu, Chuan Liu, Guangying Du, Chunjie Sha, Kailin Wang, Jun Lu, Baiping Sun, Yanyan Zhao, Qiaoping Wang, Hongguang Xu, Ying Li, Zhenduo Shen, Jie Jiao, Ruiying Wang, Jingwei Tian, Wanhui Liu, Lan Wang, Yong-Qiang Deng, Changlin Dou
Structure and function analysis of a potent human neutralizing antibody CA521FALA against SARS-CoV-2. Communications biology 4 (1) (2021)
Qing Ye, Jia Zhou, Qi He, Rui-Ting Li, Guan Yang, Yao Zhang, Shu-Jia Wu, Qi Chen, Jia-Hui Shi, Rong-Rong Zhang, Hui-Ming Zhu, Hong-Ying Qiu, Tao Zhang, Yong-Qiang Deng, Xiao-Feng Li, Jian-Feng Liu, Ping Xu, Xiao Yang, Cheng-Feng Qin
SARS-CoV-2 infection in the mouse olfactory system. Cell discovery 7 (1) (2021)
Hongjing Gu, Qi Chen, Guan Yang, Lei He, Hang Fan, Yong-Qiang Deng, Yanxiao Wang, Yue Teng, Zhongpeng Zhao, Yujun Cui, Yuchang Li, Xiao-Feng Li, Jiangfan Li, Na-Na Zhang, Xiaolan Yang, Shaolong Chen, Yan Guo, Guang-Yu Zhao, Xiliang Wang, De-Yan Luo, Hui Wang, Guan Yang, Yan Li, Gencheng Han, Yuxian He, Xiaojun Zhou, Shusheng Geng, Xiaoli Sheng, Shibo Jiang, Shihui Sun, Cheng-Feng Qin, Yusen Zhou
Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy. Science (New York, N.Y.) 369 (6511) (2020)
Zhe Lv, Yong-Qiang Deng, Qing Ye, Lei Cao, Chun-Yun Sun, Changfa Fan, Wei Jin Huang, Shihui Sun, Yao Sun, Ling Zhu, Qi Chen, Nan Wang, Jianhui Nie, Zhen Cui, Dandan Zhu, Neil Shaw, Xiao-Feng Li, Qianqian Li, Liangzhi Xie, You-Chun Wang, Zihe Rao, Cheng-Feng Qin, Xiangxi Wang
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody. Science (New York, N.Y.) 369 (6510) (2020)

Yong-Qiang Deng.css-eqlu8i{font-size:small;padding-left:4px;} (Yongqiang Deng)

Publication Activity (10 Years)

Top Topics

Top Venues

Yong-Qiang Deng (Yongqiang Deng)